Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
•
1 like•159 views
Recommended
Recommended
More Related Content
Similar to Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Similar to Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 (20)
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
- 1. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Report Details: Published:August 2012 No. of Pages: 207 Price: Single User License – US$2500 Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. Scope - Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts,
- 2. Viscosupplementation and Bone Growth Stimulators. - Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the four market categories. Data from 2004 to 2011, forecast forward for seven years to 2018. - 2011 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. - Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS. - Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Medtronic, Inc., Baxter International Inc., Biomet, Inc., Orthofix International N.V., Smith & Nephew Plc, Globus Medical, Inc., Wright Medical Group, Inc., Stryker Corporation, DJO Finance LLC, Ferring International Center S.A., Seikagaku Corporation, Anika Therapeutics, Inc. and Alphatec Holdings, Inc.. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Get your copy of this report @ http://www.reportsnreports.com/reports/190152-orthobiologics-market-outlook-in-brics-brazil-russia-india-china- south-africa-to-2018.html Major points covered in Table of Contents of this report include 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 8 1.2 List of Figures 12 2 Introduction 15 2.1 What is This Report About? 15 3 Orthobiologics in BRICS 16 3.1 Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16 3.2 Orthobiologics, BRICS, Company share (2010-2011) 21 4 Orthobiologics In Brazil 23 4.1 Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23 4.2 Bone Graft Substitutes In Brazil 28
- 3. 4.2.1 Bone Graft Substitutes, Brazil, Overall Revenue (2004-2018) 28 4.2.2 Bone Graft Substitutes, Brazil, Overall Volume (2004-2018) 32 4.2.3 Bone Graft Substitutes, Brazil, Average Price (2004-2018) 35 4.3 Bone Allografts In Brazil 36 4.3.1 Bone Allografts, Brazil, Overall Revenue (2004-2018) 36 4.4 Viscosupplementation In Brazil 38 4.4.1 Viscosupplementation, Brazil, Overall Revenue (2004-2018) 38 4.4.2 Viscosupplementation, Brazil, Overall Volume (2004-2018) 40 4.4.3 Viscosupplementation, Brazil, Average Price (2004-2018) 42 4.5 Bone Growth Stimulators In Brazil 43 4.5.1 Bone Growth Stimulators, Brazil, Overall Revenue (2004-2018) 43 4.5.2 Bone Growth Stimulators, Brazil, Overall Volume (2004-2018) 45 4.5.3 Bone Growth Stimulators, Brazil, Average Price (2004-2018) 47 4.6 Orthobiologics, Brazil, Distribution Share (2010-2011) 48 4.7 Orthobiologics, Brazil, Company Share (2010-2011) 49 5 Orthobiologics In Russian Federation 51 5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51 5.2 Bone Graft Substitutes In Russian Federation 57 5.2.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2004-2018) 57 5.2.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2004-2018) 61 5.2.3 Bone Graft Substitutes, Russian Federation, Average Price (2004-2018) 65 5.3 Bone Allografts In Russian Federation 66 5.3.1 Bone Allografts, Russian Federation, Overall Revenue (2004-2018) 66 5.4 Bone Growth Stimulators In Russian Federation 68 5.4.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2004-2018) 68 5.4.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2004-2018) 71 5.4.3 Bone Growth Stimulators, Russian Federation, Average Price (2004-2018) 73 5.5 Viscosupplementation In Russian Federation 74 5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2004-2018) 74 5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2004-2018) 77 5.5.3 Viscosupplementation, Russian Federation, Average Price (2004-2018) 79 5.6 Orthobiologics, Russian Federation, Distribution Share (2010-2011) 80 5.7 Orthobiologics, Russian Federation, Company Share (2010-2011) 81 6 Orthobiologics In India 83 6.1 Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83 6.2 Bone Graft Substitutes In India 88 6.2.1 Bone Graft Substitutes, India, Overall Revenue (2004-2018) 88 6.2.2 Bone Graft Substitutes, India, Overall Volume (2004-2018) 92 6.2.3 Bone Graft Substitutes, India, Average Price (2004-2018) 95 6.3 Bone Allografts In India 96 6.3.1 Bone Allografts, India, Overall Revenue (2004-2018) 96 6.4 Viscosupplementation In India 98
- 4. 6.4.1 Viscosupplementation, India, Overall Revenue (2004-2018) 98 6.4.2 Viscosupplementation, India, Overall Volume (2004-2018) 100 6.4.3 Viscosupplementation, India, Average Price (2004-2018) 102 6.5 Bone Growth Stimulators In India 103 6.5.1 Bone Growth Stimulators, India, Overall Revenue (2004-2018) 103 6.5.2 Bone Growth Stimulators, India, Overall Volume (2004-2018) 105 6.5.3 Bone Growth Stimulators, India, Average Price (2004-2018) 107 6.6 Orthobiologics, India, Distribution Share (2010-2011) 108 6.7 Orthobiologics, India, Company Share (2010-2011) 109 7 Orthobiologics In China 111 7.1 Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111 7.2 Bone Graft Substitutes In China 116 7.2.1 Bone Graft Substitutes, China, Overall Revenue (2004-2018) 116 7.2.2 Bone Graft Substitutes, China, Overall Volume (2004-2018) 120 7.2.3 Bone Graft Substitutes, China, Average Price (2004-2018) 123 7.3 Bone Allografts In China 124 7.3.1 Bone Allografts, China, Overall Revenue (2004-2018) 124 7.4 Viscosupplementation In China 126 7.4.1 Viscosupplementation, China, Overall Revenue (2004-2018) 126 7.4.2 Viscosupplementation, China, Overall Volume (2004-2018) 128 7.4.3 Viscosupplementation, China, Average Price (2004-2018) 130 7.5 Bone Growth Stimulators In China 131 7.5.1 Bone Growth Stimulators, China, Overall Revenue (2004-2018) 131 7.5.2 Bone Growth Stimulators, China, Overall Volume (2004-2018) 133 7.5.3 Bone Growth Stimulators, China, Average Price (2004-2018) 135 7.6 Orthobiologics, China, Distribution Share (2010-2011) 136 7.7 Orthobiologics, China, Company Share (2010-2011) 137 8 Orthobiologics In South Africa 139 8.1 Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139 8.2 Bone Graft Substitutes In South Africa 145 8.2.1 Bone Graft Substitutes, South Africa, Overall Revenue (2004-2018) 145 8.2.2 Bone Graft Substitutes, South Africa, Overall Volume (2004-2018) 149 8.2.3 Bone Graft Substitutes, South Africa, Average Price (2004-2018) 153 8.3 Bone Allografts In South Africa 154 8.3.1 Bone Allografts, South Africa, Overall Revenue (2004-2018) 154 8.4 Viscosupplementation In South Africa 156 8.4.1 Viscosupplementation, South Africa, Overall Revenue (2004-2018) 156 8.4.2 Viscosupplementation, South Africa, Overall Volume (2004-2018) 158 8.4.3 Viscosupplementation, South Africa, Average Price (2004-2018) 160 8.5 Bone Growth Stimulators In South Africa 161 8.5.1 Bone Growth Stimulators, South Africa, Overall Revenue (2004-2018) 161 8.5.2 Bone Growth Stimulators, South Africa, Overall Volume (2004-2018) 165
- 5. 8.5.3 Bone Growth Stimulators, South Africa, Average Price (2004-2018) 167 8.6 Orthobiologics, South Africa, Distribution Share (2010-2011) 168 8.7 Orthobiologics, South Africa, Company Share (2010-2011) 169 9 Overview of Key Companies in BRICS Orthobiologics Market 171 9.1 DePuy, Inc. 171 9.1.1 Company Overview 171 9.1.2 Share in the BRICS Orthobiologics Market 172 9.2 Genzyme Corporation 173 9.2.1 Company Overview 173 9.2.2 Share in the BRICS Orthobiologics Market 174 9.3 Synthes, Inc. 175 9.3.1 Company Overview 175 9.3.2 Share in the BRICS Orthobiologics Market 176 9.4 Medtronic, Inc. 177 9.4.1 Company Overview 177 9.4.2 Share in the BRICS Orthobiologics Market 178 9.5 Baxter International Inc. 179 9.5.1 Company Overview 179 9.5.2 Share in the BRICS Orthobiologics Market 180 9.6 Biomet, Inc. 181 9.6.1 Company Overview 181 9.6.2 Share in the BRICS Orthobiologics Market 182 9.7 Orthofix International N.V. 183 9.7.1 Company Overview 183 9.7.2 Share in the BRICS Orthobiologics Market 184 9.8 Smith & Nephew Plc 185 9.8.1 Company Overview 185 9.8.2 Share in the BRICS Orthobiologics Market 186 9.9 Globus Medical, Inc. 187 9.9.1 Company Overview 187 9.10 Wright Medical Group, Inc. 188 9.10.1 Company Overview 188 9.10.2 Share in the BRICS Orthobiologics Market 189 9.11 Stryker Corporation 190 9.11.1 Company Overview 190 9.11.2 Share in the BRICS Orthobiologics Market 191 9.12 DJO Finance LLC 192 9.12.1 Company Overview 192 9.12.2 Share in the BRICS Orthobiologics Market 193 9.13 Ferring International Center S.A. 194 9.13.1 Company Overview 194 9.13.2 Share in the BRICS Orthobiologics Market 195
- 6. 9.14 Seikagaku Corporation 196 9.14.1 Company Overview 196 9.15 Anika Therapeutics, Inc. 197 9.15.1 Company Overview 197 9.15.2 Share in the BRICS Orthobiologics Market 198 9.16 Alphatec Holdings, Inc. 199 9.16.1 Company Overview 199 9.16.2 Share in the BRICS Orthobiologics Market 200 9.17 NuVasive, Inc. 201 9.17.1 Company Overview 201 10 Appendix 202 10.1 Definitions of Markets Covered in the Report 203 10.1.1 Orthobiologics 203 10.2 Research Methodology 204 10.3 Secondary Research 204 10.4 Primary Research 205 10.5 Models 205 10.6 Forecasts 206 10.7 Expert Panels 206 10.8 GlobalData Consulting 206 10.9 Currency Conversion 207 10.10 Contact Us 207 10.11 Disclaimer 207 1.1 List of Tables Table 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16 Table 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18 Table 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20 Table 4: Orthobiologics, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22 Table 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23 Table 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25 Table 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27 Table 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004- 2011 29 Table 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 31 Table 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 33 Table 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34 Table 12: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2004-2011 35 Table 13: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2011-2018 35 Table 14: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36 Table 15: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37
- 7. Table 16: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38 Table 17: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39 Table 18: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40 Table 19: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41 Table 20: Viscosupplementation, Brazil, Average Price ($), Historic, 2004-2011 42 Table 21: Viscosupplementation, Brazil, Average Price ($), Forecast, 2011-2018 42 Table 22: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43 Table 23: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44 Table 24: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45 Table 25: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46 Table 26: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2004-2011 47 Table 27: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2011-2018 47 Table 28: Orthobiologics, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 48 Table 29: Orthobiologics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50 Table 30: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 52 Table 31: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54 Table 32: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56 Table 33: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 58 Table 34: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 60 Table 35: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004- 2011 62 Table 36: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 64 Table 37: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011 65 Table 38: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018 65 Table 39: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66 Table 40: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011- 2018 67 Table 41: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 69 Table 42: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70 Table 43: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71 Table 44: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72
- 8. Table 45: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2004-2011 73 Table 46: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2011-2018 73 Table 47: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 75 Table 48: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76 Table 49: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77 Table 50: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78 Table 51: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2004-2011 79 Table 52: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2011-2018 79 Table 53: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 80 Table 54: Orthobiologics, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 82 Table 55: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83 Table 56: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 85 Table 57: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 87 Table 58: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 89 Table 59: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 91 Table 60: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 93 Table 61: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94 Table 62: Bone Graft Substitutes, India, Average Price ($), Historic, 2004-2011 95 Table 63: Bone Graft Substitutes, India, Average Price ($), Forecast, 2011-2018 95 Table 64: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96 Table 65: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97 Table 66: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98 Table 67: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99 Table 68: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100 Table 69: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101 Table 70: Viscosupplementation, India, Average Price ($), Historic, 2004-2011 102 Table 71: Viscosupplementation, India, Average Price ($), Forecast, 2011-2018 102 Table 72: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103 Table 73: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104 Table 74: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105 Table 75: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106 Table 76: Bone Growth Stimulators, India, Average Price ($), Historic, 2004-2011 107 Table 77: Bone Growth Stimulators, India, Average Price ($), Forecast, 2011-2018 107
- 9. Table 78: Orthobiologics, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 108 Table 79: Orthobiologics, India, Company Share by Revenue ($m), USD Constant, 2010-2011 110 Table 80: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111 Table 81: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 113 Table 82: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 115 Table 83: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 117 Table 84: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 119 Table 85: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 121 Table 86: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122 Table 87: Bone Graft Substitutes, China, Average Price ($), Historic, 2004-2011 123 Table 88: Bone Graft Substitutes, China, Average Price ($), Forecast, 2011-2018 123 Table 89: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124 Table 90: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125 Table 91: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126 Table 92: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127 Table 93: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128 Table 94: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129 Table 95: Viscosupplementation, China, Average Price ($), Historic, 2004-2011 130 Table 96: Viscosupplementation, China, Average Price ($), Forecast, 2011-2018 130 Table 97: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131 Table 98: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132 Table 99: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133 Table 100: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134 Table 101: Bone Growth Stimulators, China, Average Price ($), Historic, 2004-2011 135 Table 102: Bone Growth Stimulators, China, Average Price ($), Forecast, 2011-2018 135 Table 103: Orthobiologics, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 136 Table 104: Orthobiologics, China, Company Share by Revenue ($m), USD Constant, 2010-2011 138 Table 105: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 140 Table 106: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004- 2011 142 Table 107: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011- 2018 144 Table 108: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 146 Table 109: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant,
- 10. Forecast, 2011-2018 148 Table 110: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 150 Table 111: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011- 2018 152 Table 112: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2004-2011 153 Table 113: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2011-2018 153 Table 114: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154 Table 115: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155 Table 116: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004- 2011 156 Table 117: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011- 2018 157 Table 118: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158 Table 119: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159 Table 120: Viscosupplementation, South Africa, Average Price ($), Historic, 2004-2011 160 Table 121: Viscosupplementation, South Africa, Average Price ($), Forecast, 2011-2018 160 Table 122: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004- 2011 162 Table 123: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011- 2018 164 Table 124: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165 Table 125: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166 Table 126: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2004-2011 167 Table 127: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2011-2018 167 Table 128: Orthobiologics, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 168 Table 129: Orthobiologics, South Africa, Company Share by Revenue ($m), USD Constant, 2010- 2011 170 Table 130: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 172 Table 131: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 174 Table 132: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 176 Table 133: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 178 Table 134: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 180 Table 135: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 182 Table 136: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2011 184 Table 137: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2011 186 Table 138: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 187 Table 139: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 189 Table 140: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 191 Table 141: DJO Finance LLC, Revenue ($m), BRICS Orthobiologics Market, 2011 193 Table 142: Ferring International Center S.A., Revenue ($m), BRICS Orthobiologics Market, 2011
- 11. 195 Table 143: Seikagaku Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 196 Table 144: Anika Therapeutics, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 198 Table 145: Alphatec Holdings, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 200 1.2 List of Figures Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16 Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17 Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19 Figure 4: Orthobiologics, BRICS, Company share (%), 2011 21 Figure 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23 Figure 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24 Figure 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26 Figure 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 28 Figure 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 30 Figure 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 32 Figure 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34 Figure 12: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36 Figure 13: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37 Figure 14: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38 Figure 15: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39 Figure 16: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40 Figure 17: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41 Figure 18: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43 Figure 19: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44 Figure 20: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45 Figure 21: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46 Figure 22: Orthobiologics, Brazil, Company Share (%), 2011 49 Figure 23: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51 Figure 24: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 53 Figure 25: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 55 Figure 26: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 57 Figure 27: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 59 Figure 28: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic,
- 12. 2004-2011 61 Figure 29: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 63 Figure 30: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004- 2011 66 Figure 31: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011- 2018 67 Figure 32: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 68 Figure 33: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70 Figure 34: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71 Figure 35: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72 Figure 36: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 74 Figure 37: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76 Figure 38: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77 Figure 39: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78 Figure 40: Orthobiologics, Russian Federation, Company Share (%), 2011 81 Figure 41: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83 Figure 42: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 84 Figure 43: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 86 Figure 44: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 88 Figure 45: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 90 Figure 46: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 92 Figure 47: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94 Figure 48: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96 Figure 49: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97 Figure 50: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98 Figure 51: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99 Figure 52: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100 Figure 53: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101 Figure 54: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103 Figure 55: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104 Figure 56: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105 Figure 57: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106 Figure 58: Orthobiologics, India, Company Share (%), 2011 109
- 13. Figure 59: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111 Figure 60: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 112 Figure 61: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 114 Figure 62: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 116 Figure 63: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 118 Figure 64: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 120 Figure 65: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122 Figure 66: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124 Figure 67: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125 Figure 68: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126 Figure 69: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127 Figure 70: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128 Figure 71: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129 Figure 72: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131 Figure 73: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132 Figure 74: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133 Figure 75: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134 Figure 76: Orthobiologics, China, Company Share (%), 2011 137 Figure 77: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139 Figure 78: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004- 2011 141 Figure 79: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011- 2018 143 Figure 80: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 145 Figure 81: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 147 Figure 82: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 149 Figure 83: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 151 Figure 84: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154 Figure 85: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155 Figure 86: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004- 2011 156 Figure 87: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011- 2018 157 Figure 88: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158
- 14. Figure 89: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159 Figure 90: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004- 2011 161 Figure 91: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011- 2018 163 Figure 92: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165 Figure 93: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166 Figure 94: Orthobiologics, South Africa, Company Share (%), 2011 169 Figure 95: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 172 Figure 96: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 174 Figure 97: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 176 Figure 98: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 178 Figure 99: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2011 180 Figure 100: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 182 Figure 101: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2011 184 Figure 102: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2011 186 Figure 103: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 189 Contact: sales@reportsandreports.com for more information.